Browsing Tag
glucagon-like peptide-1 receptor agonists
11 posts
GLP-1 Drugs Might Cut Dementia Risk in Half
[ad_1] This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on…
April 8, 2025
Can Weight Loss Drugs Also Treat Addiction?
[ad_1] A new study provides more evidence that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) used to treat…
October 18, 2024
GLP-1 RAs Reduce Suicidal Behavior in Adolescents
[ad_1] Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third…
October 16, 2024
Liraglutide Reduces BMI by Almost 6% in Children Aged 6 to 12
[ad_1] The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in…
September 11, 2024
Promising New Data Support GLP-1s for Dementia Prevention
[ad_1] A new study supports the potential to repurpose glucagon-like peptide 1 (GLP-1) receptor agonists, used to treat…
July 31, 2024
As GLP-1 Demand Goes Up, Access and Coverage Go Down
[ad_1] ORLANDO, Fla — Experts debating the pressing issue of how to prioritize patients in the increasingly common…
July 18, 2024
Semaglutide Reduces CV Events and Diabetes Risk
[ad_1] ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and…
June 24, 2024
Tirzepatide Significantly Reduces Sleep Disruptions
[ad_1] ORLANDO, FL — The diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for…
June 22, 2024
Semaglutide Improves Taste Sensitivity in Women With Obesity
[ad_1] The glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Ozempic, Wegovy) enhances taste sensitivity, changes brain responses to sweet…
June 3, 2024
Semaglutide outperforms liraglutide for weight regain after surgery
[ad_1] TOP LINE: Semaglutide 1.0 mg/week resulted in greater weight loss than liraglutide 3.0 mg/day in the treatment…
June 9, 2023